CLCS
CELL SOURCE INC by Cell Source, Inc. (CLCS)
$
32About CELL SOURCE INC by Cell Source, Inc. (CLCS)
Cell Source, Inc. is a biotechnology company, which focuses on developing cell therapy treatments based on the management of immune tolerance. Its Veto Cell immune system management technology is an immune tolerance biotechnology that enables the selective blocking of immune responses. The Veto Cell platform roadmap consists of two main programs: VETO CAR-T (with and without HSCT) and Veto Cell Organ Transplantation. The company was founded on June 6, 2012 and is headquartered in New York, NY.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.84
52 Week Low
$0.00
Market cap
13.9M
Dividend yield
0.00%
Volume
--
Avg. volume
14,109
P/E ratio
-1.98
CELL SOURCE INC by Cell Source, Inc. News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$0.84
52 Week Low
$0.00
Market cap
13.9M
Dividend yield
0.00%
Volume
--
Avg. volume
14,109
P/E ratio
-1.98